Log in to save to my catalogue

Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patien...

Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patien...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_3069202206

Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study

About this item

Full title

Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study

Publisher

United States: Public Library of Science

Journal title

PloS one, 2024-01, Vol.19 (1), p.e0294590-e0294590

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

The treatment efficiency and predictors of atezolizumab plus bevacizumab therapy for unresectable hepatocellular carcinoma in real-world practice have not been established. This study aimed to assess the efficacy and safety of atezolizumab plus bevacizumab and to investigate predictors of progression-free survival and overall survival. Patients wit...

Alternative Titles

Full title

Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_3069202206

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_3069202206

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0294590

How to access this item